Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

857 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overcoming steroid unresponsiveness in airways disease.
Adcock IM, Chou PC, Durham A, Ford P. Adcock IM, et al. Among authors: ford p. Biochem Soc Trans. 2009 Aug;37(Pt 4):824-9. doi: 10.1042/BST0370824. Biochem Soc Trans. 2009. PMID: 19614602 Review.
Epigenetics and airways disease.
Adcock IM, Ford P, Ito K, Barnes PJ. Adcock IM, et al. Among authors: ford p. Respir Res. 2006 Feb 6;7(1):21. doi: 10.1186/1465-9921-7-21. Respir Res. 2006. PMID: 16460559 Free PMC article. Review.
Steroid resistance in asthma: mechanisms and treatment options.
Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF. Adcock IM, et al. Among authors: ford pa. Curr Allergy Asthma Rep. 2008 Apr;8(2):171-8. doi: 10.1007/s11882-008-0028-4. Curr Allergy Asthma Rep. 2008. PMID: 18417060 Review.
Chronic cough and Holmes-Adie syndrome.
Ford PA, Barnes PJ, Usmani OS. Ford PA, et al. Lancet. 2007 Jan 27;369(9558):342. doi: 10.1016/S0140-6736(07)60156-1. Lancet. 2007. PMID: 17258674 No abstract available.
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschöpe C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C, Heymans S. de Boer RA, et al. Among authors: ford p. Eur J Heart Fail. 2019 Mar;21(3):272-285. doi: 10.1002/ejhf.1406. Epub 2019 Feb 4. Eur J Heart Fail. 2019. PMID: 30714667 Free PMC article.
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).
Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M. Maher TM, et al. Among authors: ford p. BMJ Open Respir Res. 2019 May 21;6(1):e000422. doi: 10.1136/bmjresp-2019-000422. eCollection 2019. BMJ Open Respir Res. 2019. PMID: 31179008 Free PMC article.
857 results